The U.S. Department of Health and Human Services (HHS) is rolling back several health IT certification requirements that could reduce certification costs for technology developers. But they may leave hospitals and health systems holding more responsibility for evaluating the safety and performance of the AI tools they purchase. The post Looser Health IT Certification Requirements…
TAKOMA PARK, Md. — Friday night lights took on a whole new meaning at a high school here in this suburb of Washington, D.C. Instead of fans packing stadium bleachers to watch football, on this recent October weekend the gymnasium, hallways, and parking areas were jammed with people desperately seeking healthcare at a free pop-up…
(Oona Zenda/KFF Health News) As Grace Griffin and her husband were welcoming their long-awaited baby — a daughter — Griffin found herself worried about looming medical bills and unsure if their family could pay for the care they needed. “This whole experience has me wondering (keeping me up at night, actually): Can we ever afford…
Most hospitals buy their AI. Charité – Universitätsmedizin Berlin, Europe’s largest academic medical center and ranked eighth in the world by Newsweek, is developing its own. Charité has consolidated its scattered AI projects into a single Institute for Artificial Intelligence in Medicine and switched on Clé, an in-house platform that runs across research, teaching, patient…
Health tech companies made several major funding announcements in October. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in October appeared first on MedCity News.
In this episode, we’re joined by Dr. Rani Aravamudhan, senior medical director of Artemis at Nomi Health. We discuss Nomi Health’s new research on endometriosis. The post MedCity FemFwd: The Gaps in Endometriosis Care appeared first on MedCity News.
Inovio’s Voceryq will compete with a Precigen product that last year became the first FDA-approved drug for recurrent respiratory papillomatosis, or RRP. While the two immunotherapies carry the same $460,000 list price, Inovio executives claim their product has another competitive advantage. The post Inovio’s DNA-Based Immunotherapy Lands Speedy FDA Nod for Rare Type of Tumor…
The federal government is testing whether artificial intelligence can help Medicare identify unnecessary medical care, speed up the prior authorization process, and reduce healthcare spending. But a new report based on evidence recovered from a lawsuit raises concerns about the AI experiment. The post 7 Potential Problems with Medicare’s AI Prior Authorization Experiment appeared first…
This brief examines how the budget reconciliation law expanded access to HSA-eligible plans and accounts on the ACA Marketplaces and what these changes means for enrollees